Table 2.

Patient and tumor characteristics of patients with esophageal or gastric cancer according to hospital with low, middle and high probability of receiving treatment with curative intent

	Esophageal cancer							Gastric cancer
	probability							probability
	low		middle		high		p value	low		middle		high		p value
	N	%	N	%	N	%
ALL	477	100%	548	100%	625	100%		507	100%	327	100%	545	100%
Sex							0.75							0.53
Female	136	29%	147	27%	179	29%		199	39%	122	37%	224	41%
Male	341	71%	401	73%	446	71%		308	61%	205	63%	321	59%
Age							0.09							0.72
< 60	100	21%	83	15%	111	18%		76	15%	46	14%	71	13%
60—74	239	50%	287	52%	340	54%		169	33%	122	37%	195	36%
≥ 75	138	29%	178	32%	174	28%		262	52%	159	49%	279	51%
cT Classification							0.59							0.03
cT1	28	6%	35	6%	34	5%		21	4%	12	4%	29	5%
cT2	133	28%	143	26%	197	32%		202	40%	117	36%	190	35%
cT3	239	50%	273	50%	305	49%		130	26%	66	20%	117	21%
cT4	6	1%	10	2%	10	2%		16	3%	20	6%	19	3%
cTX	71	15%	87	16%	79	13%		138	27%	112	34%	190	35%
cN Classification							0.22							0.7
cN0	176	37%	211	39%	272	44%		275	54%	182	56%	317	58%
cN +	260	55%	288	53%	303	48%		161	32%	99	30%	151	28%
cNX	41	9%	49	9%	50	8%		71	14%	46	14%	77	14%
Histology							0.07							0.475
Adenocarcinoma	348	73%	386	70%	477	76%		491	97%	321	98%	532	98%
Squamous cell carcinoma	123	26%	145	26%	134	21%		NA		NA		NA
Not otherwise specified	6	1%	17	3%	14	2%		16	3%	6	2%	13	2%
Number of Comorbidities							0.83							0.01
0 comorbidities	192	40%	213	39%	259	41%		166	33%	127	39%	219	40%
1 comorbidity	151	32%	184	34%	204	33%		187	37%	111	34%	153	28%
2 or more	116	24%	117	21%	141	23%		135	27%	74	23%	150	28%
unknown	18	4%	34	6%	21	3%		19	4%	15	5%	23	4%
ECOG performance status							0.53							0.001
ECOG 0 and 1	319	67%	368	67%	415	66%		260	51%	141	43%	267	49%
ECOG 2	39	8%	53	10%	43	7%		37	7%	24	7%	51	9%
ECOG 3 and 4	16	3%	16	3%	17	3%		31	6%	10	3%	12	2%
Unknown ECOG	103	22%	111	20%	150	24%		179	35%	152	46%	215	39%